{
    "Trade/Device Name(s)": [
        "Randox Liquid Urine Controls Level 2",
        "Randox Liquid Urine Controls Level 3"
    ],
    "Submitter Information": "Randox Laboratories Limited",
    "510(k) Number": "K110904",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class I, reserved",
    "Product Code(s)": [
        "JJY"
    ],
    "Summary Letter Date": "13 September 2011",
    "Summary Letter Received Date": "16 September 2011",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Amylase",
        "Calcium",
        "Chloride",
        "Cortisol",
        "Creatinine",
        "Glucose",
        "hCG pregnancy",
        "Magnesium",
        "Microalbumin",
        "Osmolality",
        "pH",
        "Inorganic Phosphate",
        "Potassium",
        "Total Protein",
        "Sodium",
        "Specific Gravity",
        "Urea",
        "Uric Acid"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Randox Liquid Urine Controls Level 2 and Level 3 as quality control materials for chemistry assays.",
    "Indications for Use Summary": "For in vitro diagnostic use in the quality control of specified analyte assays on various clinical chemistry systems.",
    "fda_folder": "Clinical Chemistry"
}